SREBF1 and hepatocellular carcinoma: Activated CCRK led to induction of mTORC1/4E-BP1/S6K/SREBP1 signaling pathways, resulting in recruitment of MDSCs, which enhance progression to HCC, by initiating metabolic reprogramming and modulating an immunosuppressive microenvironment (167).